Literature DB >> 32224025

Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.

Stefania Colantuono1, Chiara Pellicano1, Giorgia Leodori1, Francesco Cilia2, Marco Francone2, Marcella Visentini3.   

Abstract

Entities:  

Year:  2020        PMID： 32224025     DOI： 10.1016/j.alit.2020.03.001

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  3 in total

Review 1.  A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Haruki Koike; Ryoji Nishi; Satoru Yagi; Soma Furukawa; Yuki Fukami; Masahiro Iijima; Masahisa Katsuno
Journal:  Adv Ther       Date:  2022-09-24       Impact factor: 4.070

Review 2.  Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis.

Authors:  Yasuhiko Koga; Haruka Aoki-Saito; Yosuke Kamide; Makiko Sato; Hiroaki Tsurumaki; Masakiyo Yatomi; Tamotsu Ishizuka; Takeshi Hisada
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

3.  The Diagnostic Challenge of Eosinophilic Granulomatosis With Polyangiitis Presenting as Acute Eosinophilic Myocarditis: Case Report and Literature Review.

Authors:  Hiroyuki Yamamoto; Katsuya Hashimoto; Yoshihiko Ikeda; Jun Isogai; Toru Hashimoto
Journal:  Front Cardiovasc Med       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.